Digital Therapeutics - Switzerland

  • Switzerland
  • Revenue in the Digital Therapeutics market is projected to reach €0.11k in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1,814.47%, resulting in a projected market volume of €282,900.00k by 2029.
  • User penetration will be 43.41% in 2024 and is expected to hit 101.51% by 2029.
  • The average revenue per user (ARPU) is expected to amount to €0.00.
  • In global comparison, most revenue will be generated United States (€2.92k in 2024).
 
Marché
 
Région
 
Comparaison de régions
 
Monnaie
 

Analyst Opinion

The Digital Therapeutics market in Switzerland is witnessing significant growth and development, driven by various factors shaping the healthcare landscape in the country.

Customer preferences:
Customers in Switzerland are increasingly seeking non-invasive and personalized treatment options for chronic conditions such as diabetes, mental health disorders, cardiovascular diseases, and musculoskeletal issues. They are inclined towards digital therapeutics products that offer convenience, real-time monitoring, and tailored interventions to manage their health effectively.

Trends in the market:
In Switzerland, the Digital Therapeutics market is experiencing a surge in demand for solutions that provide remote patient monitoring, behavior modification, and self-management tools. The integration of advanced technologies like artificial intelligence and machine learning in digital therapeutics products is enhancing their effectiveness and driving adoption among healthcare providers and patients alike. Moreover, the emphasis on preventive healthcare and value-based care models is propelling the uptake of digital therapeutics in managing chronic conditions in Switzerland.

Local special circumstances:
Switzerland boasts a robust healthcare system characterized by high-quality care, advanced infrastructure, and a strong focus on innovation. The country has a tech-savvy population that is receptive to digital health solutions, creating a favorable environment for the growth of the Digital Therapeutics market. Additionally, the presence of leading pharmaceutical and biotech companies in Switzerland fosters collaboration and innovation in the development of digital therapeutics products.

Underlying macroeconomic factors:
The rising healthcare costs and the burden of chronic diseases in Switzerland are driving the adoption of cost-effective and efficient healthcare solutions like digital therapeutics. The favorable regulatory environment, supportive government initiatives, and increasing investments in digital health technologies are further fueling the expansion of the Digital Therapeutics market in the country. Additionally, the growing aging population and the need for remote healthcare management solutions are contributing to the growing acceptance of digital therapeutics in Switzerland.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on revenues and user data of relevant mobile applications and consumer electronics companies.

Modeling approach / Market size:

Market sizes are determined through a combined top-down and bottom-up approach, building on a specific rationale for each market segment. As a basis for evaluating markets, we use annual financial reports of key players, industry reports, third-party reports, and survey results from primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as GDP, population, internet penetration, smartphone penetration, consumer spending, and healthcare spending. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, the S-curve function and exponential trend smoothing are well suited for forecasting digital products and services due to the non-linear growth of technology adoption.

Additional notes:

The market is updated twice a year in case market dynamics change. The impact of the COVID-19 pandemic and the Russia-Ukraine war is considered at a country-specific level.

Vue d’ensemble

  • Revenue
  • Analyst Opinion
  • Users
  • Global Comparison
  • Methodology
  • Key Market Indicators
Veuillez patienter

Contact

Des questions ? Nous nous ferons un plaisir de vous aider.
Statista Locations
Contact Camille Dubois
Camille Dubois
Customer Relations

Lun - Ven, 9:00 - 18:00 h (EST)

Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (États-Unis)

Lun - Ven, 9:00 - 18:00 h (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asie)

Lun - Ven, 9:00 - 17:00 h (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asie)

Lun - Ven, 10:00 - 18:00 h (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Lun - Ven, 9:00 - 18:00 h (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Amérique latine)

Lun - Ven, 9:00 - 18:00 h (EST)